NCT06203912 2026-03-05Donor Immune Cells (TGFbi NK Cells) and Isatuximab for the Treatment of Relapsed or Refractory Multiple MyelomaOhio State University Comprehensive Cancer CenterPhase 1 Active not recruiting3 enrolled